Thermo Fisher Scientific (TMO) recently announced an increase in profit for its fourth quarter, exceeding the estimates provided by Wall Street analysts. In comparison to the same period last year, the company's earnings have risen, coming in at $1.63 billion, or $4.20 per share, in contrast to last year's $1.58 billion, or $4.01 per share.
If we exclude certain items, Thermo Fisher Scientific's adjusted earnings for the period were reported to be $2.20 billion or $5.67 per share. In comparison to the average expectation of $5.64 per share predicted by analysts, as per data compiled by Thomson Reuters, this is a significant increase. However, it should be noted that analysts' estimates typically do not include exceptional items.
Despite these positive earnings, the company's revenue for the quarter did experience a decrease, reducing by 4.9% from $11.45 billion last year to a lesser $10.89 billion.
Taking a closer look at Thermo Fisher Scientific's earnings at a glance (GAAP), we observe that the Earnings (Q4) of $1.63 Bln were higher than last year's $1.58 Bln. Similarly, the company's Earnings Per Share (EPS) for Q4 at $4.20 surpasses the previous year's $4.01. Comparing this to the Analyst Estimate of $5.64, we can appreciate the company's performance. However, as mentioned earlier, the Revenue for Q4 did experience a slight drop, coming in at $10.89 Bln compared to last year's $11.45 Bln.
